Source: https://www.journal-irioh.ru/jour/article/view/426
Timestamp: 2019-04-25 02:17:32+00:00

Document:
2. Boden W.E., van Gilst W.H., Scheldewaert R.G. et al. // Lancet. - 2000. - № 355 (9217). - p. 1751-1756.
3. Gibson R.S., Boden W.E., Therous P. et al. // N. Engl. J. Med. - 1986. - № 315. - p. 423-9.
4. Goldstein R.E., Boccuzzi S.J., Cruess D. et al. // Circulation. - 1991. - V. 83. - p. 52-60.
5. Grossman E., Messerli F.H. // Progress in Cardiovascular. - Dis. 2004. - V. 47 (1). - p. 34-57.
6. Hricik D.E., Levine B.S., Adrogue H.J. et al. // J. Hum. Hypertens. - 1996. - V. 10 (11). - p. 769-774.
7. Multicenter DiltiazemPostinfarction Trial Research Group. // N. Engl. J. Med. - 1988. - V. 319. - p. 385-392.
8. Moss A.J., Oakes D., Rubison M. et al. // Am. J. Cardiol. - 1991. - V. 68. - p. 429-433.
9. Nadeau C., Hilton D., Savard D. et al. //Am. J. Cardiol. - 1995. - V. 75. - p. 555-558.
10. Pérez-Maraver M. 1., Carrera M.J., Micaló T. et al. // Diabetes Res. Clin. Pract. - 2005. - V. 70 (1). - p. 13-19.
11. Toyo-Oka T., Nayler W.G. // Blood Pressure. - 1996. suppl. - p. 206-208.
12. Weiss R.J., Bent B. // J. Clin. Hypertens. - 1987. - V. 3 (2). - p. 135-143.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.